Aliases & Classifications for Dental Pulp Disease

MalaCards integrated aliases for Dental Pulp Disease:

Name: Dental Pulp Disease 12 15
Dental Pulp Diseases 44 73
Disorder of Pulp of Tooth 12
Dental Pulp Disorder 12
Pulp Disorder 12

Classifications:



External Ids:

Disease Ontology 12 DOID:5330
MeSH 44 D003788
NCIt 50 C34530
SNOMED-CT 68 57203004
UMLS 73 C0011405

Summaries for Dental Pulp Disease

MalaCards based summary : Dental Pulp Disease, also known as dental pulp diseases, is related to paroxysmal extreme pain disorder and diverticulitis of colon, and has symptoms including toothache An important gene associated with Dental Pulp Disease is TRPV1 (Transient Receptor Potential Cation Channel Subfamily V Member 1), and among its related pathways/superpathways are Toll Comparative Pathway and Bacterial infections in CF airways. The drugs Zinc and Epinephrine have been mentioned in the context of this disorder. Affiliated tissues include bone, lung and liver.

Wikipedia : 76 The pulp, or endodontium, is the part in the center of a tooth made up of living connective tissue and... more...

Related Diseases for Dental Pulp Disease

Diseases related to Dental Pulp Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 144)
# Related Disease Score Top Affiliating Genes
1 paroxysmal extreme pain disorder 10.2 SCN11A TRPV1
2 diverticulitis of colon 10.2 NPS TRPV1
3 recurrent corneal erosion 10.2 CXCL8 IL1B
4 bagassosis 10.2 CXCL8 IL1B
5 peptic esophagitis 10.2 CXCL8 IL1B
6 staphylococcal toxic shock syndrome 10.2 IL1B TNF
7 funisitis 10.2 CXCL8 IL1B
8 leiomyoma cutis 10.2 TAC1 TRPV1
9 kashin-beck disease 10.2 IL1B TNF
10 rheumatoid lung disease 10.2 IL1B TNF
11 vulvar vestibulitis syndrome 10.2 IL1B TNF
12 burns 10.2 IL1B TNF
13 glossitis 10.2 IL1B TNF
14 laryngitis 10.2 IL1B TNF
15 ascaris lumbricoides infection 10.2 CXCL8 IL1B
16 retinitis pigmentosa 60 10.2 IL1B TNF
17 irritant dermatitis 10.2 IL1B TNF
18 acute vascular insufficiency of intestine 10.2 IL1B TNF
19 congenital cytomegalovirus 10.2 IL1B TNF
20 actinic prurigo 10.1 IL1B TNF
21 tungiasis 10.1 CXCL8 TNF
22 osteosclerotic myeloma 10.1 IL1B TNF
23 streptococcal toxic-shock syndrome 10.1 CXCL8 TNF
24 trigeminal nerve disease 10.1 TAC1 TRPV1
25 poems syndrome 10.1 IL1B TNF
26 stachybotrys chartarum 10.1 TNF IL1B
27 central nervous system vasculitis 10.1 TNF IL1B
28 dental fluorosis 10.1 AMELX DSPP
29 retinitis pigmentosa 68 10.1 NPS TAC1
30 trichuriasis 10.1 CXCL8 TNF
31 esophagitis 10.1 CXCL8 IL1B TRPV1
32 epicondylitis 10.1 NPS TAC1
33 stomach disease 10.1 CXCL8 IL1B TRPV1
34 cardiac sarcoidosis 10.1 CXCL8 TNF
35 vaginitis 10.1 IL1B CXCL8
36 lacrimal apparatus disease 10.1 IL1B TNF TRPV1
37 gastroesophageal reflux 10.1 CXCL8 IL1B TRPV1
38 clonorchiasis 10.1 CXCL8 TNF
39 autoimmune disease of central nervous system 10.1 IL1B TNF TRPV1
40 jejunoileitis 10.1 TNF IL1B
41 mononeuropathy 10.1 TRPV1 TAC1
42 autoimmune disease of the nervous system 10.1 IL1B TNF TRPV1
43 vaginal disease 10.1 IL1B CXCL8
44 arteries, anomalies of 10.1 IL1B TNF TRPV1
45 glucose metabolism disease 10.1 IL1B TNF TRPV1
46 immune system disease 10.1 IL1B TNF TRPV1
47 acquired metabolic disease 10.1 IL1B TNF TRPV1
48 nervous system disease 10.1 IL1B TNF TRPV1
49 somatoform disorder 10.1 IL1B TAC1 TRPV1
50 mycobacterium abscessus 10.1 TNF CXCL8

Graphical network of the top 20 diseases related to Dental Pulp Disease:



Diseases related to Dental Pulp Disease

Symptoms & Phenotypes for Dental Pulp Disease

UMLS symptoms related to Dental Pulp Disease:


toothache

Drugs & Therapeutics for Dental Pulp Disease

Drugs for Dental Pulp Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 189)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Zinc Approved, Investigational Phase 4,Phase 2,Phase 1,Not Applicable,Early Phase 1 7440-66-6
2
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 51-43-4 5816
3
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 137-58-6 3676
4
Racepinephrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 329-65-7 838
5
Prednisolone Approved, Vet_approved Phase 4,Phase 3 50-24-8 5755
6
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3 302-25-0
7
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3 83-43-2 6741
8
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3 2921-57-5
9
Tramadol Approved, Investigational Phase 4,Phase 1,Phase 2 27203-92-5 33741
10
Mepivacaine Approved, Vet_approved Phase 4,Phase 2,Phase 3 96-88-8 4062
11
Ibuprofen Approved Phase 4,Phase 2,Not Applicable 15687-27-1 3672
12
Ketoprofen Approved, Vet_approved Phase 4 22071-15-4 3825
13
Methamphetamine Approved, Illicit Phase 4,Not Applicable 537-46-2 10836
14
Dopamine Approved Phase 4,Not Applicable 51-61-6, 62-31-7 681
15
Metronidazole Approved Phase 4,Phase 3,Phase 1,Not Applicable,Early Phase 1 443-48-1 4173
16
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 1,Not Applicable,Early Phase 1 85721-33-1 2764
17
Bacitracin Approved, Vet_approved Phase 4,Phase 1,Early Phase 1 1405-87-4 10909430 439542
18
Neomycin Approved, Vet_approved Phase 4,Phase 1,Early Phase 1 1404-04-2 8378
19
Xylometazoline Approved, Investigational Phase 4 526-36-3 5709
20
Ethanol Approved Phase 4,Phase 2,Not Applicable 64-17-5 702
21
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
22
Cefixime Approved, Investigational Phase 4 79350-37-1 5362065 54362
23
Simvastatin Approved Phase 4 79902-63-9 54454
24
Pseudoephedrine Approved Phase 4 90-82-4 7028
25
Oxymetazoline Approved, Investigational Phase 4 1491-59-4 4636
26
Tetracaine Approved, Vet_approved Phase 4 94-24-6 5411
27
Phenylephrine Approved Phase 4 59-42-7 6041
28
Ephedrine Approved Phase 4 299-42-3 9294
29
Lactitol Investigational Phase 4,Phase 2,Phase 3 585-86-4 3871
30
Prednisolone hemisuccinate Experimental Phase 4,Phase 3 2920-86-7
31
Bismuth Phase 4,Phase 2,Phase 3,Early Phase 1 7440-69-9 16682734 105143
32 Calcium, Dietary Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
33 Bone Density Conservation Agents Phase 4,Phase 2,Phase 3,Not Applicable
34 Anti-Bacterial Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
35 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
36 Anesthetics Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1
37 Central Nervous System Depressants Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
38 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
39 Anti-Inflammatory Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
40 Analgesics Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
41 Analgesics, Non-Narcotic Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
42 Antirheumatic Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
43 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
44 Cyclooxygenase Inhibitors Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
45 Pharmaceutical Solutions Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
46 Antibiotics, Antitubercular Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
47 Antitubercular Agents Phase 4,Phase 1,Early Phase 1,Not Applicable
48 Sodium Channel Blockers Phase 4,Phase 3,Phase 2,Not Applicable
49 Anti-Arrhythmia Agents Phase 4,Phase 3,Phase 2,Not Applicable
50 Anesthetics, Local Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 185)
# Name Status NCT ID Phase Drugs
1 Success and Color Stability of MTA Pulpotomized Primary Molars: an RCT Unknown status NCT02702505 Phase 4
2 Success Rate Evaluation of Miniature Pulpotomy With MTA in Primary Molars Unknown status NCT02286648 Phase 4 Formocresol;Mineral Trioxide Aggregate
3 Postoperative Pain in Single-visit and Multiple-visit Retreatment Cases Completed NCT03042377 Phase 4 Multiple-Visit-"Calcium Hydroxide";Multiple-Visit-"Corticosteroid Paste";Multiple-Visit-"Antibiotic Paste"
4 Efficacy Study of Articaine Versus Lidocaine as Supplemental Infiltration in Inflamed Molars Completed NCT01496846 Phase 4 IANB Articaine;SUP Articaine;SUP Lidocaine
5 Oral Glucocorticoids Effect on Post Endodontic Pain Completed NCT02819648 Phase 4 Prednisolone
6 Mepivacaine-Tramadol on the Success of Inferior Alveolar Nerve Block in Symptomatic Irreversible Pulpitis Completed NCT02110966 Phase 4 Mepivacaine;Mepivacaine plus Tramadol
7 Dexketoprofen Trometamol in Postoperative Endodontic Pain Completed NCT02086097 Phase 4 Dexketoprofen trometamol;Ibuprofen;PLACEBO
8 Anesthetic Efficacy in Irreversible Pulpitis Completed NCT02054767 Phase 4 Intervention: inferior alveolar nerve block injection
9 Anesthetic Efficacy of Articaine and Lidocaine in Lower Molars With Irreversible Pulpits Completed NCT01912755 Phase 4 4% articaine with 1:100,000 epinephrine;2% lidocaine with 1:100,000 epinephrine
10 Prefabricated Endodontic Posts: Glass Fiber Versus Titanium - A Randomized Controlled Pilot- Trial Completed NCT01520766 Phase 4
11 Efficiency of Triple Antibiotic Paste, Ciprofloxacin/Propolis, Ciprofloxacin/Metronidazole, Propolis/Metronidazole Combinations on Revascularization Process of Immature Necrotic Maxillary Incisors of Patients 8-18 Years Old. Completed NCT03533231 Phase 4
12 Evaluation of Postoperative Pain After Using 3MIX-TATIN Versus Calcium Hydroxide Iodoform Paste In Necrotic Primary Molars Treated by Lesion Sterilization and Tissue Repair Therapy Completed NCT03084601 Phase 4 Calcium Hydroxide, Iodoform, paste;3-mixtatin
13 Comparison of Two Dental Techniques Used to Treat Teeth Which Have Become Infected or Painful Following Trauma Completed NCT01817413 Phase 4
14 Efficacy of Calcium Silicate Pulp-capping; a Randomized Controlled Clinical Trial Active, not recruiting NCT02201641 Phase 4
15 : Pulpal Blood Flow With the Use of Intra-nasal Anesthetic Not yet recruiting NCT03368391 Phase 4 tetracaine HCl and oxymetazoline HCL;2% Lidocaine with 1:100,000 epinephrine;3% Mepivacaine with 1:100,000 epinephrine;saline intranasal;saline infiltration
16 Assessment of Postoperative Pain After Using Various Intracanal Medication in Patients With Necrotic Pulp Not yet recruiting NCT03692286 Phase 4 Silver Nanoparticles in gel form;Calcium Hydroxide Intracanal medication
17 Efficacy of Tetracaine/Oxymetazoline Nasal Spray for Endodontic Treatment Withdrawn NCT03502135 Phase 4 Tetracaine HCl and oxymetazoline HCl nasal spray
18 Diclofenac Potassium on IANB Efficacy in Symptomatic Irreversible Pulpitis Unknown status NCT03163420 Phase 2, Phase 3 Diclofenac potassium
19 Effect of Addition of Mannitol to Bupivacaine on IANB Success and Post-endodontic Pain Completed NCT03749408 Phase 2, Phase 3 bupivacaine plus mannitol;bupivacaine alone
20 Effect of Preoperative Diclofenac Potassium on Postoperative Endodontic Pain Completed NCT03341260 Phase 2, Phase 3 Diclofenac Potassium 50mg Tab.;Placebo
21 Pretreatment Aceclofenac Effect on Pain and Analgesic Intake After Endodontic Treatment Completed NCT03335007 Phase 2, Phase 3 Aceclofenac
22 Effect of Preoperative Diclofenac Potassium on Articaine Buccal Infitration Success Completed NCT03174860 Phase 2, Phase 3 Diclofenac Potassium 50mg Tab;Placebo
23 Pre-operative Aceclofenac on the Anesthetic Efficacy of IANB in Symptomatic Irreversible Pulpitis Completed NCT03146481 Phase 2, Phase 3 Aceclofenac
24 Effect of Inferior Alveolar and Gow-Gates Nerve Block Techniques for Symptomatic Mandibular Molars Completed NCT03117491 Phase 3
25 4% Articaine and 2% Lidocaine by Intraligamentary Technique in Irreversible Pulpitis Completed NCT02807298 Phase 3 4%articaine;2% Lignocaine;Epinephrine
26 Calcium Hydroxide, Mineral Trioxide Aggregate and Biodentine (Trademark) as Direct Pulp Capping of Permanent Teeth Completed NCT02492841 Phase 2, Phase 3 Mineral trioxide aggregate;Calcium hydroxide;Biodentine
27 Effect of Sodium Bicarbonate Buffered Lidocaine on the Success of IAN Block of Teeth With Irreversible Pulpitis Completed NCT02226913 Phase 3 2% lidocaine with 1:80,000 epinephrine;sodium bicarbonate;placebo
28 Human Pulpal Response After Pulp Capping With Four Different Agents Completed NCT01468480 Phase 2, Phase 3 Pro Root MTA;Pro Root MTA- single visit;MultiCal;Dycal
29 Partial Pulpotomy on Caries Free Human Teeth Completed NCT01420718 Phase 2, Phase 3 MTA;iRoot BP
30 Assessment of a New Apexification Method for Patients Presenting a Non Vital Immature Tooth Completed NCT00472173 Phase 3 Mineral Trioxide Aggregate;Calcium hydroxide
31 Efficacy of Oral Prednisolone on Pain Reduction in Emergency Care of Acute Irreversible Pulpitis Completed NCT02629042 Phase 3 prednisolone
32 Nanodiamond-Gutta Percha Composite Biomaterials for Root Canal Therapy Recruiting NCT03376984 Phase 2, Phase 3
33 Anesthetic Efficacy of 2% Mepivacaine Versus 4% Articaine Recruiting NCT03725579 Phase 2, Phase 3 mepivicane hydrochloride;articane hydrochloride
34 Clinical Comparison of Endodontically Treated Teeth Restored With Fiber Posts or Cast Metal Posts Recruiting NCT01461239 Phase 3
35 Evaluation the Post Operative Pain of Endodontic Treated Molar Tooth With Race and Reciprocal Systems Among Bandarabbas Patients in 2017 Recruiting NCT03488836 Phase 2, Phase 3
36 Regenerative Endodontic Procedure of Immature Permanent Teeth With L-PRF: a Pilot Controlled, Clinical Trial Active, not recruiting NCT02437708 Phase 3
37 Revascularization of Immature Anterior Necrotic Teeth Not yet recruiting NCT03504332 Phase 3
38 A Clinical Study: the Antibacterial Effect of Insoluble Antibacterial Nanoparticles (IABN) Incorporated in Dental Materials for Root Canal Treatment Unknown status NCT01167985 Phase 2
39 Effect Of Different Lining Materials in Stepwise Excavation Unknown status NCT01730287 Phase 2 Control;Calcium Hydroxide;Mineral Trioxide Aggregate(MTA);CEM cement
40 Efficacy of Chlorexidine as Intracanal Medicament in Primary Teeth Unknown status NCT00624572 Phase 2 chlorexidine
41 Photodynamic Therapy in Endodontic Treatment Completed NCT02824601 Phase 2 Calcium hydroxide
42 Efficacy of Block Injection of an Anti Inflammatory Medicine in Patients With Mandibular Dental Pain Completed NCT03410212 Phase 2 Ketorolac Tromethamine
43 Application of Photodynamic Therapy and Diode Laser for Endodontic Therapy of Young Permanent Teeth Completed NCT03074136 Phase 2 0.5% Sodium hypochlorite
44 Premedication Efficacy of Ketorolac Infiltration on Post Endodontic Pain Completed NCT02923687 Phase 2 Ketorolac Tromethamine;Placebo
45 Endodontic Treatment of Primary Teeth Using Mineral Trioxide Aggregate Paste Completed NCT02887456 Phase 2 Endodontic treatment using Vitapex;Endodontic treatment using MTA paste
46 Premedication Efficacy of Oral Ketorolac and Ketorolac/ Acetaminophen on Post Treatment Pain Completed NCT02614118 Phase 2 Ketorolac tromethamine;Acetaminophen;Placebo
47 Efficacy of Pressure Massage and Topical Gel on Pain During Intra Oral Injections Completed NCT02601924 Phase 2 20% Benzocain (Master-Dent, Monroe, NC)
48 Effect of Premedication on Success of Inferior Alveolar Nerve Block Injection Completed NCT02601911 Phase 2 Ketorolac Tromethamine;Acetaminophen
49 Effect of Fentanyl on the Rate of Anesthesia Completed NCT01794533 Phase 2 Lidocaine with Epinephrine+ Normal saline;Lidocaine with Epinephrine + fentanyl
50 Effect of Sufentanil on the Rate of Anesthesia Completed NCT01572116 Phase 2 Lidocaine with Epinephrine+ Normal saline;Lidocaine with Epinephrine + sufentanil

Search NIH Clinical Center for Dental Pulp Disease

Cochrane evidence based reviews: dental pulp diseases

Genetic Tests for Dental Pulp Disease

Anatomical Context for Dental Pulp Disease

MalaCards organs/tissues related to Dental Pulp Disease:

41
Bone, Lung, Liver, Colon, Lymph Node, Prostate, Salivary Gland

Publications for Dental Pulp Disease

Articles related to Dental Pulp Disease:

# Title Authors Year
1
Effects of combining CBCT technology with visual root canal recurrence in treatment of elderly patients with dental pulp disease. ( 28338208 )
2017
2
Diagnostic imaging in veterinary dental practice. Dental pulp disease in a river otter. ( 23971840 )
2013
3
Aids in diagnosing dental pulp diseases. ( 21026127 )
1946

Variations for Dental Pulp Disease

Expression for Dental Pulp Disease

Search GEO for disease gene expression data for Dental Pulp Disease.

Pathways for Dental Pulp Disease

Pathways related to Dental Pulp Disease according to GeneCards Suite gene sharing:

(show all 21)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.03 CXCL8 ECSIT IL1B TNF
2
Show member pathways
11.98 CXCL8 IL1B TNF
3 11.8 CXCL8 IL1B TNF
4 11.77 CXCL8 IL1B TNF
5 11.7 CXCL8 IL1B TNF
6 11.67 CXCL8 IL1B TNF
7 11.65 CXCL8 IL1B TNF
8 11.61 CXCL8 IL1B TNF
9 11.51 CXCL8 IL1B TNF
10
Show member pathways
11.5 CXCL8 ECSIT IL1B TNF
11 11.38 CXCL8 IL1B TNF
12
Show member pathways
11.34 CXCL8 IL1B TNF
13 11.24 CXCL8 IL1B TNF
14 11.14 CXCL8 IL1B TAC1 TNF
15 11.12 CXCL8 IL1B TNF
16 11.06 IL1B TNF
17 11.02 CXCL8 IL1B TNF
18 10.96 CXCL8 TNF
19 10.92 IL1B TNF
20 10.85 CXCL8 TNF
21 10.76 IL1B TNF

GO Terms for Dental Pulp Disease

Cellular components related to Dental Pulp Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.28 AMELX CXCL8 DSPP IL1B LRRC7 MCAM

Biological processes related to Dental Pulp Disease according to GeneCards Suite gene sharing:

(show all 27)
# Name GO ID Score Top Affiliating Genes
1 regulation of signaling receptor activity GO:0010469 9.91 AMELX CXCL8 IL1B TNF
2 cellular response to lipopolysaccharide GO:0071222 9.8 CXCL8 IL1B TNF
3 positive regulation of cytosolic calcium ion concentration GO:0007204 9.79 IL1B TAC1 TRPV1
4 positive regulation of interleukin-8 production GO:0032757 9.63 IL1B TNF
5 negative regulation of neurogenesis GO:0050768 9.62 IL1B TNF
6 positive regulation of neutrophil chemotaxis GO:0090023 9.62 CXCL8 IL1B
7 response to pain GO:0048265 9.6 TAC1 TRPV1
8 microglial cell activation GO:0001774 9.59 TNF TRPV1
9 embryonic digestive tract development GO:0048566 9.58 CXCL8 TNF
10 negative regulation of lipid catabolic process GO:0050995 9.58 IL1B TNF
11 positive regulation of glial cell proliferation GO:0060252 9.57 IL1B TNF
12 regulation of I-kappaB kinase/NF-kappaB signaling GO:0043122 9.56 IL1B TNF
13 positive regulation of membrane protein ectodomain proteolysis GO:0051044 9.55 IL1B TNF
14 positive regulation of heterotypic cell-cell adhesion GO:0034116 9.54 IL1B TNF
15 response to carbohydrate GO:0009743 9.52 DSPP IL1B
16 positive regulation of synaptic transmission, GABAergic GO:0032230 9.51 NPS TAC1
17 positive regulation of chemokine biosynthetic process GO:0045080 9.49 IL1B TNF
18 regulation of establishment of endothelial barrier GO:1903140 9.48 IL1B TNF
19 positive regulation of neuroinflammatory response GO:0150078 9.46 IL1B TNF
20 positive regulation of action potential GO:0045760 9.43 NPS TAC1
21 positive regulation of nitric oxide biosynthetic process GO:0045429 9.43 IL1B TNF TRPV1
22 positive regulation of fever generation GO:0031622 9.4 IL1B TNF
23 chronic inflammatory response to antigenic stimulus GO:0002439 9.37 IL1B TNF
24 sequestering of triglyceride GO:0030730 9.32 IL1B TNF
25 fever generation GO:0001660 9.16 IL1B TRPV1
26 inflammatory response GO:0006954 9.02 CXCL8 IL1B TAC1 TNF TRPV1
27 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 8.96 IL1B TNF

Sources for Dental Pulp Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....